Cite
HARVARD Citation
Dispenzieri, A. et al. (n.d.). Soluble suppression of tumorigenicity 2 (sST2), but not galactin‐3, adds to prognostication in patients with systemic AL amyloidosis independent of NT‐proBNP and troponin T. American journal of hematology. 90 (6), pp. 524-528. [Online].